Epstein Secrets

d a former board member of Rockefeller University. Mr. Epstein is actively involved in the Santa Fe Institute, the Theoretical Biology Initiative at the Institute for Advanced Study in Princeton, the Quantum Gravity Program at the University of Pennsylvania, and also sits on the Mind, Brain & Behavior Advisory Committee at Harv

onset of late Alzheimers. The discovery is critical, explains Dr. Bin Zhang, a co-lead author of the study and Associate Professor of Genetics and Genomic Sciences at Mount Sinai. Because we can now "evaluate drugs that impact the TREM2-TYROBP pathway as potential therapies... and design more specific compounds

cience and a former board member of Rockefeller University. He is actively involved in the Santa Fe Institute, the Theoretical Biology Initiative at the Institute for Advanced Study in Princeton and also sits on the Mind, Brain & Behavior Advisory Committee at Harvard University. EFTA_R1_00457162 EFTA01973137

ntly connected to Alzheimer's. The discovery is critical, Dr. Bin Zhang explained, a co-author of the study and Associate Professor of Genetics and Genomic Sciences at Mount Sinai. "We can now evaluate drugs that impact the TFtEM2- TYROBP pathway as potential therapies... and design more specific compounds that t

cience and a former board member of Rockefeller University. He is actively involved in the Santa Fe Institute, the Theoretical Biology Initiative at the Institute for Advanced Study in Princeton and also sits on the Mind, Brain & Behavior Advisory Committee at Harvard University. EFTA00583077

ntly connected to Alzheimer's. The discovery is critical, Dr. Bin Zhang explained, a co-author of the study and Associate Professor of Genetics and Genomic Sciences at Mount Sinai. "We can now evaluate drugs that impact the TREM2- TYROBP pathway as potential therapies... and design more specific compounds that ta

d a former board member of Rockefeller University. Mr. Epstein is actively involved in the Santa Fe Institute, the Theoretical Biology Initiative at the Institute for Advanced Study in Princeton, the Quantum Gravity Program at the University of Pennsylvania, and also sits on the Mind, Brain & Behavior Advisory Committee at Harv

onset of late Alzheimers. The discovery is critical, explains Dr. Bin Zhang, a co-lead author of the study and Associate Professor of Genetics and Genomic Sciences at Mount Sinai. Because we can now "evaluate drugs that impact the TREM2-TYROBP pathway as potential therapies... and design more specific compounds